Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

DXCM

Dexcom Inc

Dec 07 • 04:00PM ET

118.89

Dollar change +0.95
Percentage change 0.81	%

Healthcare • Medical Devices • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	NDX, S&P 500	P/E	131.70	EPS (ttm)	0.90	Insider Own	1.44%	Shs Outstand	386.30M	Perf Week	2.92%
Market Cap	45.94B	Forward P/E	69.51	EPS next Y	1.71	Insider Trans	-0.50%	Shs Float	380.80M	Perf Month	24.90%
Income	377.00M	PEG	3.88	EPS next Q	0.42	Inst Own	97.22%	Short Float / Ratio	4.66% / 3.53	Perf Quarter	13.93%
Sales	3.40B	P/S	13.50	EPS this Y	64.08%	Inst Trans	-0.36%	Short Interest	17.75M	Perf Half Y	-1.85%
Book/sh	5.87	P/B	20.26	EPS next Y	19.82%	ROA	6.56%	Target Price	124.80	Perf Year	1.76%
Cash/sh	8.39	P/C	14.18	EPS next 5Y	33.95%	ROE	18.42%	52W Range	74.75 - 139.55	Perf YTD	4.99%
Dividend	-	P/FCF	91.91	EPS past 5Y	-	ROI	7.79%	52W High	-14.80%	Beta	1.22
Dividend %	-	Quick Ratio	2.50	Sales past 5Y	32.62%	Gross Margin	63.67%	52W Low	59.05%	ATR	3.52
Employees	7600	Current Ratio	2.80	Sales Q/Q	26.69%	Oper. Margin	14.88%	RSI (14)	74.86	Volatility	2.41% 3.20%
Optionable	Yes	Debt/Eq	1.20	EPS Q/Q	18.67%	Profit Margin	11.08%	Rel Volume	0.48	Prev Close	117.94
Shortable	Yes	LT Debt/Eq	1.13	Earnings	Oct 26 AMC	Payout	0.00%	Avg Volume	5.03M	Price	118.89
Recom	1.38	SMA20	10.07%	SMA50	24.56%	SMA200	6.71%	Volume	2,391,744	Change	0.81%

Date	Action	Analyst	Rating Change	Price Target Change
May-30-23	Resumed	Morgan Stanley	Equal-Weight	$131
Apr-17-23	Upgrade	Raymond James	Outperform → Strong Buy	$127 → $138
Mar-29-23	Initiated	UBS	Buy	$142
Jan-26-23	Initiated	Wolfe Research	Outperform	$121
Oct-18-22	Initiated	Barclays	Equal Weight	$103
Oct-12-22	Initiated	Jefferies	Buy	$125
Jul-15-22	Initiated	Bernstein	Outperform	$105
Mar-02-22	Resumed	BofA Securities	Buy	$500
Feb-03-22	Upgrade	BTIG Research	Neutral → Buy	$535
Jan-19-22	Upgrade	Wells Fargo	Equal Weight → Overweight	$575
Jan-07-22	Upgrade	Guggenheim	Neutral → Buy	$580
Oct-18-21	Downgrade	Guggenheim	Buy → Neutral
Jul-21-21	Resumed	Cowen	Outperform	$540 → $525
May-28-21	Upgrade	Wells Fargo	Underweight → Equal Weight	$380
May-25-21	Initiated	Barclays	Overweight	$500
Apr-15-21	Initiated	Atlantic Equities	Overweight	$438
Jan-06-21	Upgrade	UBS	Neutral → Buy	$410 → $445
Oct-02-20	Downgrade	Wells Fargo	Equal Weight → Underweight	$420 → $350
May-27-20	Reiterated	Piper Sandler	Overweight	$375 → $450
May-14-20	Initiated	Wells Fargo	Equal Weight	$420

Show Previous Ratings

Today 03:37AM	Dexcom, Hologic picked to outperform in 2024: William Blair (MedTech Dive)
Dec-06-23 01:06PM	Dexcom G7 is Now the Most Accurate, Smallest, Easy-to-Use CGM Connected to the Tandem t:slim X2 Insulin Pump (Business Wire)
12:45PM	Is DexCom (DXCM) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
08:40AM	Dexcom G7, the Smallest, Most Accurate, Easy-to-Use CGM Now Connects to the Tandem t:slim X2 Insulin Pump (Business Wire)
Dec-05-23 02:03PM	DexCom Stock Earns Healthy Relative Strength Rating Upgrade (Investor's Business Daily)
11:05AM	Loading…
11:05AM	Insider Sell Alert: EVP Chief Legal Officer Michael Brown Sells 3,612 Shares of DexCom Inc (DXCM) (GuruFocus.com)
07:23AM	Should You Hold DexCom (DXCM)? (Insider Monkey)
Nov-30-23 08:07AM	11 Best Long Term Growth Stocks To Invest In (Insider Monkey)
Nov-28-23 09:45AM	Why DexCom (DXCM) is a Top Growth Stock for the Long-Term (Zacks)
Nov-26-23 09:58AM	Goldman Sachs Top 15 Stock Picks for 2024 (Insider Monkey)
05:54AM	5 Best Medical Technology Stocks To Buy Now (Insider Monkey)
Nov-25-23 09:04AM	Insider Sell: EVP Chief Human Resources Officer Sadie Stern Sells Shares of DexCom Inc (DXCM) (GuruFocus.com)
Nov-21-23 08:30AM	Dexcom Announces Upcoming Conference Presentation (Business Wire)
06:30AM	3 Growth Stocks to Buy With $1,000 Right Now (Motley Fool)
Nov-20-23 12:45PM	DexCom (DXCM) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
11:56AM	Loading…
11:56AM	13 Stocks That Outperform the S&P 500 Every Year for the Last 5 Years (Insider Monkey)
06:03AM	Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here's How. (Motley Fool)
01:33AM	Investors' Concerns over the Impact of GLP-1 Drugs Dragged DexCom (DXCM) (Insider Monkey)
Nov-19-23 09:00AM	2 Stock Split Growth Stocks to Buy and Hold (Motley Fool)
Nov-17-23 10:54AM	Obesity Drugs Put These Stocks on a Crash DietNow Theyre Rebounding (The Wall Street Journal)
10:07AM	Is DexCom the Next Big Growth Stock? (Motley Fool)
09:15AM	Reasons to Add DexCom (DXCM) Stock to Your Portfolio Now (Zacks)
Nov-16-23 10:00AM	Could DexCom Stock Help You Become a Millionaire? (Motley Fool)
Nov-14-23 12:01AM	Dexcom Unveils Portrait Gallery to Portray Emotional Highs and Lows of Living With Diabetes on World Diabetes Day (Business Wire)
Nov-13-23 09:31AM	Novo Nordisk's Wegovy could reduce heart risks in new trial (Yahoo Finance Video)
Nov-08-23 09:37AM	2 Medical Device Companies Experiencing Strong Demand Even as Weight-Loss Drugs Rise in Popularity (Motley Fool)
04:00AM	Historic Victory as People With Diabetes Win Access to Life-Changing Technology, But Almost Half Dont Understand the Benefits1-2 (Business Wire)
Nov-03-23 12:27PM	Inari Medical (NARI) Q3 Earnings and Revenues Beat Estimates (Zacks)
12:22PM	AMN Healthcare (AMN) Q3 Earnings and Revenues Beat Estimates (Zacks)
09:35AM	Cardinal Health (CAH) Beats on Q1 Earnings, Ups '24 EPS View (Zacks)
07:57AM	Loading…
07:57AM	Prestige Consumer (PBH) Q2 Revenues Top, Margins Expand (Zacks)
07:52AM	Omnicell (OMCL) Q3 Earnings and Revenues Beat, Margins Down (Zacks)
Nov-02-23 12:25PM	Avanos (AVNS) Q3 Earnings Top Estimates, Margins Contract (Zacks)
12:20PM	Why DexCom (DXCM) Might be Well Poised for a Surge (Zacks)
12:16PM	Nevro (NVRO) Q3 Earnings Top Estimates, FY23 Revenue View Up (Zacks)
10:32AM	McKesson (MCK) Beats on Q2 Earnings, Raises '23 EPS View (Zacks)
09:57AM	2 Growth Stocks That Could Help Set You Up for Life (Motley Fool)
09:55AM	Wall Street Analysts Think DexCom (DXCM) Could Surge 36.81%: Read This Before Placing a Bet (Zacks)
09:30AM	DexCom (DXCM) Just Reclaimed the 50-Day Moving Average (Zacks)
07:59AM	Tandem Diabetes (TNDM) Posts Wider Q3 Loss, Trims '23 Sales View (Zacks)
Nov-01-23 07:02PM	Analyst Report: DexCom, Inc. (Morningstar Research) +5.97%
Oct-31-23 12:45PM	3 Reasons Growth Investors Will Love DexCom (DXCM) (Zacks)
12:00PM	What Makes DexCom (DXCM) a New Buy Stock (Zacks)
04:12AM	12 Best Internet of Things (IoT) Stocks To Buy (Insider Monkey)
Oct-30-23 06:57PM	Analyst Report: DexCom, Inc. (Morningstar Research)
04:22PM	11 Undervalued Mid Cap Stocks To Buy According to Analysts (Insider Monkey)
04:05PM	11 Best Long-Term Stocks To Buy For High Returns (Insider Monkey)
11:52AM	Ensign Group (ENSG) Q3 Earnings Beat on Occupancy, Stock Up 2.4% (Zacks)
06:17AM	Dexcom (DXCM) Faces Challenges Over GLP-1s' Long-Term Effects on Its Target Market (Insider Monkey)
Oct-27-23 11:00PM	Dexcom stock climbs as worries surrounding weight-loss drugs fades (CNBC TV) +10.11%
05:29PM	Analyst Report: DexCom, Inc. (Morningstar Research)
04:36PM	Stock Market Ends Week Mixed; Nasdaq Was Only Winner Friday (Investor's Business Daily)
04:05PM	Dexcom Surges 10% After Shrugging Off Weight-Loss Woes In Boosted Outlook (Investor's Business Daily)
03:19PM	Stock Market Mixed With Nasdaq Slightly Ahead; This Is How Bad October Is Going For Stocks (Investor's Business Daily)
02:52PM	Dexcom Stock Soars on Earnings. Ozempic Isnt the Threat It Was Supposed to Be. (Barrons.com)
12:37PM	DexCom, Inc. (NASDAQ:DXCM) Q3 2023 Earnings Call Transcript (Insider Monkey)
12:28PM	Markets Mixed at Midday as Tech Sector Gets a Boost From Amazon (Investopedia)
09:00AM	3 Revolutionary Stocks I'd Buy Right Now Without Hesitation (Motley Fool)
08:15AM	Q3 2023 Dexcom Inc Earnings Call (Thomson Reuters StreetEvents)
07:30AM	DexCom (DXCM) Beats on Q3 Earnings, Raises Sales Outlook (Zacks)
Oct-26-23 10:00PM	DexCom (DXCM) Q3 2023 Earnings Call Transcript (Motley Fool)
06:26PM	DexCom Inc (DXCM) Reports Q3 2023 Financial Results, Raises Revenue and Margin Guidance (GuruFocus.com)
06:00PM	DexCom (DXCM) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
05:30PM	DexCom (DXCM) Q3 Earnings and Revenues Surpass Estimates (Zacks)
05:16PM	Dexcom Surges 15% After Shrugging Off Weight-Loss Woes In Boosted Outlook (Investor's Business Daily)
04:50PM	Dexcom Shrugs Off Pressure From Weight-Loss Drugs, Boosts 2023 Outlook. Stock Pops 14%. (Investor's Business Daily)
04:19PM	DexCom: Q3 Earnings Snapshot (Associated Press Finance)
04:03PM	Dexcom Reports Third Quarter 2023 Financial Results, Raises 2023 Revenue and Margin Guidance, and Announces $500 Million Share Repurchase Program (Business Wire)
09:50AM	Here's Why DexCom (DXCM) Sold Off in Q3 (Insider Monkey)
09:15AM	2 Best Healthcare Stocks to Buy Right Now (Motley Fool)
Oct-25-23 10:21AM	MedTech Stocks to Watch for Earnings on Oct 26: WST, DXCM & More (Zacks)
09:00AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
08:45AM	Global Diabetes Care Market Size Expected To Reach $41.71 Billion By 2027 (PR Newswire)
08:17AM	DexCom (DXCM) to Report Q3 Earnings: Is a Beat in Store? (Zacks)
Oct-24-23 03:12AM	Here's Why DexCom (DXCM) Detracted in Q3 (Insider Monkey)
Oct-20-23 04:23AM	Top Investors Stock Portfolio: 10 Mid-Cap Stocks To Buy (Insider Monkey)
Oct-19-23 10:01AM	DexCom (DXCM) Earnings Expected to Grow: Should You Buy? (Zacks)
09:35AM	Does DexCom (DXCM) Have an Attractive Long-Term Runway for Growth? (Insider Monkey)
09:15AM	The 7 Best Nasdaq Stocks To Buy Now: October 2023 (InvestorPlace)
Oct-18-23 12:10PM	Can DexCom (DXCM) Keep the Earnings Surprise Streak Alive? (Zacks)
09:53AM	2 Healthcare Stocks Near Their 52-Week Lows That Could Double in Value (Motley Fool)
05:06AM	3 Stock-Split Stocks With 110% to 696% Upside, According to Select Wall Street Analysts and Pundits (Motley Fool)
Oct-17-23 06:00PM	Why the Market Dipped But DexCom (DXCM) Gained Today (Zacks)
04:43AM	Ozempic Fears Hammered DexCom Stock. The Concerns Are Overblown. (Barrons.com)
Oct-16-23 03:15PM	Why DexCom Stock Rallied on Monday (Motley Fool)
02:34PM	Analyst Report: DexCom, Inc. (Morningstar Research)
11:35AM	Unveiling DexCom (DXCM)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com)
10:23AM	Wayfair upgraded, JD.com downgraded: Wall Street's top analyst calls (The Fly)
Oct-09-23 06:00PM	DexCom (DXCM) Stock Sinks As Market Gains: What You Should Know (Zacks)
09:45AM	Here's Why DexCom (DXCM) is a Strong Growth Stock (Zacks)
09:02AM	DexCom (DXCM) to Launch Latest CGM System G7 in Canada (Zacks)
Oct-08-23 07:00AM	A Bull Market Is Coming: 2 Magnificent Stock-Split Growth Stocks That Could Soar 40% and 51%, According to Wall Street (Motley Fool)
Oct-05-23 04:44PM	Diabetes-related stocks take hit over weight loss drug craze (Yahoo Finance Video)
08:30AM	Next-Generation Dexcom G7 Continuous Glucose Monitoring System Now Available in Canada (Business Wire)
Oct-04-23 05:53AM	Glucose Game-Changers: 3 Diabetes Stocks to Grab on the Downturn (InvestorPlace)
Oct-02-23 06:00PM	DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know (Zacks)
05:27PM	Why the Weight-Loss Drug Hype Looks Overdone (Barrons.com)
01:59PM	Weight-Loss-Drug Stock Sting May Be Easing for Device Makers (Barrons.com)
12:33PM	Unveiling DexCom (DXCM)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com)
02:00AM	Dexcom Solidifies Global Leadership in Continuous Glucose Monitoring With New Clinical Data Presented at EASD (Business Wire)

DexCom, Inc. is a medical device manufacturing company, which engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6 CGM System, DexCom G6 CGM System for Medicare, Software and Mobile apps. The company was founded by John F. Burd on May 1, 1999 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Brown Michael Jon	EVP Chief Legal Officer	Dec 01	Sale	114.56	3,612	413,774	58,394	Dec 04 06:10 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Nov 24	Sale	110.80	411	45,539	124,775	Nov 27 04:00 PM
Stern Sadie	EVP Chief Human Resources Offi	Nov 22	Sale	110.00	1,176	129,360	76,400	Nov 24 03:51 PM
ALTMAN STEVEN R	Director	Nov 15	Sale	101.26	1,000	101,256	59,700	Nov 15 06:36 PM
Naganathan Girish	EVP Chief Technology Officer	Nov 09	Sale	93.27	2,725	254,161	47,725	Nov 27 07:34 PM
Regan Barry J.	EVP Operations	Nov 08	Sale	95.22	2,019	192,249	64,250	Nov 08 04:05 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Oct 23	Sale	85.75	411	35,243	125,186	Oct 23 07:43 PM
ALTMAN STEVEN R	Director	Oct 16	Sale	77.58	1,000	77,580	60,700	Oct 17 04:15 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Sep 22	Sale	88.40	411	36,332	125,597	Sep 22 06:30 PM
ALTMAN STEVEN R	Director	Sep 15	Sale	101.50	1,000	101,495	61,700	Sep 19 04:43 PM
Heller Bridgette P	Director	Sep 12	Sale	106.56	600	63,936	23,731	Sep 13 07:55 PM
Dolan Matthew Vincent	SVP Corporate Strategy-Develop	Sep 01	Sale	102.32	56	5,730	33,569	Sep 01 06:40 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Aug 23	Sale	107.03	411	43,989	126,008	Aug 23 05:42 PM
Sylvain Jereme M	EVP Chief Financial Officer	Aug 22	Sale	104.38	1,844	192,477	72,867	Aug 22 04:04 PM
Stern Sadie	EVP Chief Human Resources Offi	Aug 09	Sale	110.71	392	43,398	81,682	Aug 11 03:59 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Jul 24	Sale	130.58	412	53,799	126,419	Jul 24 05:18 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Jul 14	Sale	136.00	5,031	684,216	126,831	Jul 17 04:54 PM
Regan Barry J.	EVP Operations	Jul 10	Sale	128.05	1,989	254,691	66,269	Jul 10 05:39 PM
Stern Sadie	EVP Chief Human Resources Offi	Jul 10	Sale	128.05	392	50,196	82,074	Jul 10 05:40 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Jun 23	Sale	125.92	412	51,879	131,862	Jun 26 04:16 PM
Selvaraj Shelly Ramasamy	SVP Chief Information Officer	Jun 15	Sale	130.00	2,115	274,953	50,390	Jun 15 05:16 PM
Stern Sadie	EVP Chief Human Resources Offi	Jun 09	Sale	121.31	393	47,675	82,466	Jun 12 04:32 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	May 23	Sale	118.65	412	48,884	132,274	May 23 07:13 PM
Sylvain Jereme M	EVP Chief Financial Officer	May 22	Sale	117.58	2,400	282,192	74,711	May 23 07:12 PM
Stern Sadie	EVP Chief Human Resources Offi	May 09	Sale	120.19	393	47,235	82,859	May 09 06:24 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Apr 27	Sale	126.00	5,031	633,906	132,686	Apr 27 06:38 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Apr 24	Sale	124.68	412	51,368	137,717	Apr 26 04:36 PM
Leach Jacob Steven	EVP Chief Technology Officer	Apr 20	Sale	125.00	30,764	3,845,500	259,613	Apr 20 06:39 PM
Regan Barry J.	EVP Operations	Apr 20	Sale	124.50	2,214	275,643	68,258	Apr 20 06:39 PM
Selvaraj Shelly Ramasamy	SVP Chief Information Officer	Apr 20	Sale	125.00	2,007	250,875	52,505	Apr 20 06:39 PM
Flynn Paul R	EVP Global Revenue	Apr 17	Sale	120.00	2,781	333,720	52,112	Apr 18 04:36 PM
Stern Sadie	EVP Chief Human Resources Offi	Apr 10	Sale	112.35	393	44,154	83,252	Apr 11 04:02 PM
SAYER KEVIN R	President CEO and Chairman of	Apr 03	Sale	114.46	20,812	2,382,069	327,457	Apr 05 04:56 PM
Brown Michael Jon	EVP Chief Legal Officer	Apr 03	Sale	114.48	3,612	413,490	61,870	Apr 05 04:56 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Mar 23	Sale	116.40	5,442	633,449	138,129	Mar 27 05:08 PM
Dolan Matthew Vincent	SVP Corporate Strategy-Develop	Mar 16	Sale	115.00	2,303	264,845	33,569	Mar 17 04:14 PM
Stern Sadie	EVP Chief Human Resources Offi	Mar 14	Sale	111.86	393	43,961	83,645	Mar 15 04:03 PM
Dolan Matthew Vincent	SVP Corporate Strategy-Develop	Mar 13	Sale	106.27	6,229	661,956	35,872	Mar 14 04:46 PM
Flynn Paul R	EVP Global Revenue	Mar 13	Sale	106.27	2,782	295,643	54,893	Mar 14 04:46 PM
Regan Barry J.	EVP Operations	Mar 13	Sale	106.27	2,010	213,603	70,472	Mar 14 04:46 PM
Leach Jacob Steven	EVP Chief Technology Officer	Mar 06	Sale	114.74	18,144	2,081,822	281,089	Mar 06 08:05 PM
Dolan Matthew Vincent	SVP Corporate Strategy-Develop	Mar 06	Sale	114.40	226	25,854	26,536	Mar 06 08:04 PM
SAYER KEVIN R	President CEO and Chairman of	Mar 01	Sale	109.94	38,464	4,228,611	331,337	Mar 02 05:16 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Feb 23	Sale	111.64	412	45,996	136,464	Feb 23 06:34 PM
Sylvain Jereme M	EVP Chief Financial Officer	Feb 22	Sale	114.54	2,400	274,896	64,837	Feb 22 06:08 PM
SAYER KEVIN R	President CEO and Chairman of	Jan 30	Sale	106.15	56,844	6,034,123	369,801	Jan 31 04:07 PM
Regan Barry J.	EVP Operations	Jan 30	Sale	106.12	2,213	234,844	59,386	Jan 31 04:07 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Jan 23	Sale	107.86	412	44,438	136,876	Jan 24 04:16 PM
SAYER KEVIN R	President CEO and Chairman of	Jan 20	Sale	105.75	45,607	4,822,872	426,645	Jan 24 04:17 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Dec 23	Sale	112.57	412	46,379	137,288	Dec 27 04:29 PM
Flynn Paul R	EVP Global Revenue	Dec 08	Sale	123.50	8,988	1,110,018	55,744	Dec 08 06:07 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DXCM

Dexcom Inc

Upgrade your FINVIZ experience